thomas pulliam
University of Washington
H-index: 9
North America-United States
Top articles of thomas pulliam
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Characterization of immunosuppressive myeloid cells in Merkel cell carcinoma: correlation with resistance to PD-1 pathway blockade | Clinical Cancer Research | Shira Tabachnick-Cherny Thomas Pulliam Haroldo J Rodriguez Xinyi Fan Daniel S Hippe | 2024/3/15 |
Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma | Cell Reports Medicine | Thomas Pulliam Saumya Jani Lichen Jing Heeju Ryu Ana Jojic | 2024/2/20 |
Merkel cell polyomavirus-specific and CD39+ CLA+ CD8 T cells as blood-based predictive biomarkers for PD-1 blockade in Merkel cell carcinoma | Cell Reports Medicine | Heeju Ryu Timothy M Bi Thomas H Pulliam Korok Sarkar Candice D Church | 2024/2/9 |
Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19 | Nature Immunology | Emily S Ford Koshlan Mayer-Blackwell Lichen Jing Kerry J Laing Anton M Sholukh | 2024/1 |
1018 A transcriptional signature shared by circulating cancer-specific CD8 T cells | Saumya Jani Thomas Pulliam Nandita Kumar Ana Jojic Rashmi Bhakuni | 2023/11/1 | |
143 Genetic and transcriptional signatures of merkel cell carcinoma-specific B cells suggest a functional role in modulating cancer immunity | Journal of Investigative Dermatology | AJ Remington HJ Rodriguez T Pulliam MD Gray JJ Taylor | 2023/5/1 |
567 Merkel cell carcinomas are infiltrated by tumor-associated macrophages that counteract intratumoral CD8 T-cell benefit and correlate with resistence to PD-1 pathway blockade | Shira Tabachnick-Cherny Thomas Pulliam Haroldo Rodriguez Chevez Xinyi Fan Daniel S Hippe | 2023/11/1 | |
Resposta e resistência à imunoterapia: mecanismos dominantes no carcinoma de células Merkel | Thomas Pulliam | 2023 | |
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma | Cancer Immunology, Immunotherapy | Lisa May Ling Tachiki Daniel S Hippe Karly Williams Silva Evan Thomas Hall William McCamy | 2023/11 |
CD8+ T CELL CLONES FROM PRIOR SARS-CoV-2 INFECTION PREDOMINATE AFTER mRNA VACCINATION | Topics in Antiviral Medicine | E Ford K Mayer-Blackwell L Jing A Sholukh R St Germain | 2023 |
LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L) 1 immunotherapy | Journal of Investigative Dermatology | L Tachiki Y Moshiri Yi DS Hippe L Zawacki E Gong | 2023/9/1 |
Tempered IL-2 Signals Program PD-1 Checkpoint Blockade-Responsive Stem-like Exhausted T Cells During Priming | bioRxiv | Vandana Kalia Jim Reed Asheema Khanna Ryma Toumi Hanxi Xiao | 2023 |
Programming of checkpoint blockade responsive exhausted T cells by rheostatic IL-2 signals during priming by dendritic cells | The Journal of Immunology | Surojit Sarkar Ryma Toumi Hanxi Xiao Thomas Pulliam Jim Reed | 2023/5/1 |
Immunotherapy response and resistance: Dominant mechanisms in Merkel cell carcinoma | Thomas Pulliam | 2023 | |
434 Novel management approaches for oligometastatic merkel cell carcinoma when standard systemic therapy is not an option | Journal of Investigative Dermatology | E McClure T Akaike ET Huynh N Harikrishnan K Lachance | 2023/5/1 |
LB1029 Correlation of merkel virus-specific CD8 T cells with response to immunotherapy in merkel cell carcinoma | Journal of Investigative Dermatology | T Pulliam S Jani L Jing J Zhang R Kulikauskas | 2022/8/1 |
Development of a Merkel polyomavirus-specific T cell receptor analysis tool to guide cancer immunotherapy | Journal of Investigative Dermatology | Saumya Jani Thomas H Pulliam Koshlan Mayer-Blackwell Philip Bradley David M Koelle | 2022/10/1 |
992 Intratumoral S100A8-to-CD8 ratio in inflamed merkel cell carcinoma tumors correlates with response to PD-1 pathway blockade | Shira Tabachnick-Cherny Thomas Pulliam Haroldo Rodriguez Chevez Kimberly Smythe Rima Kulikauskas | 2022/11/1 | |
LB1044 Inhibitors of CDK4/6 and HIF2a induce immunogenic cell death in merkel cell carcinoma cells | Journal of Investigative Dermatology | JH Lee J Lee T Pulliam K Paulson V Voillet | 2022/8/1 |
Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy | Journal of Investigative Dermatology | Lisa M Tachiki Lauren Zawacki Daniel S Hippe Yasman Moshiri Nora Alexander | 2022/10/1 |
